Cargando…

Clinical values of circulating tumor cells count in localized renal cell carcinoma

BACKGROUND: Renal cancer is one of the most common malignant tumors of the urinary system, with distant metastasis occurring 30% of patients. Therefore, early detection and monitoring of tumor progression are of great significance in the diagnosis and treatment of renal cancer. However, current biom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Qirui, Li, Zhile, Zhai, Wei, Zheng, Junhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583006/ https://www.ncbi.nlm.nih.gov/pubmed/37859739 http://dx.doi.org/10.21037/tcr-22-2920

Ejemplares similares

Expression and clinical value of SALL4 in renal cell carcinomas
por: Che, Jianping, et al.
Publicado: (2020)

Sequential Circulating Tumor Cell Counts in Patients with Locally Advanced or Metastatic Hepatocellular Carcinoma: Monitoring the Treatment Response
por: Rau, Kun-Ming, et al.
Publicado: (2020)

Circulating Tumor Cell Composition in Renal Cell Carcinoma
por: Nel, Ivonne, et al.
Publicado: (2016)

Circulating Tumor Cells for the Management of Renal Cell Carcinoma
por: Broncy, Lucile, et al.
Publicado: (2018)

Characteristics of Gut Microbiota in Patients With Clear Cell Renal Cell Carcinoma
por: Chen, Yang, et al.
Publicado: (2022)

Patient-derived organoids potentiate precision medicine in advanced clear cell renal cell carcinoma
por: Xue, Yizheng, et al.
Publicado: (2022)

Circulating tumor DNA analysis of metastatic renal cell carcinoma
por: Zhang, Jingbo, et al.
Publicado: (2021)

Clinical significance of circulating tumor cells in patients with locally advanced head and neck squamous cell carcinoma
por: Liu, Kun, et al.
Publicado: (2020)

Clinical significance of the mutational landscape and fragmentation of circulating tumor DNA in renal cell carcinoma
por: Yamamoto, Yoshiyuki, et al.
Publicado: (2019)

Meta-analysis of the prognostic value of circulating tumor cells detected with the CellSearch System in colorectal cancer
por: Huang, Xuanzhang, et al.
Publicado: (2015)

Prognostic value of preoperative circulating tumor cells counts in patients with UICC stage I-IV colorectal cancer
por: Abdalla, Thaer S. A., et al.
Publicado: (2021)

Bioinformatic gene analysis for possible biomarkers and therapeutic targets of hypertension-related renal cell carcinoma
por: Huang, Wenjie, et al.
Publicado: (2020)

VHL and DNA damage repair pathway alterations as potential clinical biomarkers for first-line TKIs in metastatic clear cell renal cell carcinomas
por: Zhou, Jiale, et al.
Publicado: (2022)

Prognostic value of circulating tumor cells in the peripheral blood of patients with esophageal squamous cell carcinoma
por: Qiao, Yuanyuan, et al.
Publicado: (2017)

REGγ deficiency suppresses tumor progression via stabilizing CK1ε in renal cell carcinoma
por: Chen, Shaojun, et al.
Publicado: (2018)

Circulating Tumor Cells in Renal Cell Carcinoma: Recent Findings and Future Challenges
por: Santoni, Matteo, et al.
Publicado: (2019)

Circulating Tumor Cells as Biomarkers for Renal Cell Carcinoma: Ready for Prime Time?
por: Couto-Cunha, Anabela, et al.
Publicado: (2022)

The current status and clinical value of circulating tumor cells and circulating cell-free tumor DNA in bladder cancer
por: Riethdorf, Sabine, et al.
Publicado: (2017)

Diagnostic value of circulating cell-free DNA for renal cell carcinoma: a meta-analysis
por: Li, Yong, et al.
Publicado: (2021)

Clinical applications of circulating tumor cells in hepatocellular carcinoma
por: Hua, Yinggang, et al.
Publicado: (2022)

The clinical value of circulating tumor DNA detection in advanced non-small cell lung cancer
por: Lin, Xiao, et al.
Publicado: (2019)

High Platelet Count is a Potential Prognostic Factor of the Early Recurrence of Hepatocellular Carcinoma in the Presence of Circulating Tumor Cells
por: Lu, Zhan, et al.
Publicado: (2023)

Clinical Application Value of Circulating Cell-free DNA in Hepatocellular Carcinoma
por: Zhang, Yuyuan, et al.
Publicado: (2021)

Clinical utility of circulating tumor cell counting through CellSearch(®): the dilemma of a concept suspended in Limbo
por: Raimondi, Cristina, et al.
Publicado: (2014)

The prognostic value of circulating tumour cells (CTCs) and CTC white blood cell clusters in patients with renal cell carcinoma
por: Guan, Yibing, et al.
Publicado: (2021)

Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
por: Ye, Qianwei, et al.
Publicado: (2019)

The Prognostic Value of Circulating Tumor Cells in Asian Neuroendocrine Tumors
por: Hsieh, Jason Chia-Hsun, et al.
Publicado: (2019)

Development and initial clinical testing of a multiplexed circulating tumor cell assay in patients with clear cell renal cell carcinoma
por: Bade, Rory M., et al.
Publicado: (2021)

Prognostic value of pretreatment neutrophil count in metastatic renal cell carcinoma: a systematic review and meta-analysis
por: Shen, Jie, et al.
Publicado: (2019)

Prognostic Value of Absolute Lymphocyte Count in Patients with Advanced Renal Cell Carcinoma Treated with Nivolumab plus Ipilimumab
por: Ueda, Kosuke, et al.
Publicado: (2023)

Circulating endothelial cells are an early predictor in renal cell carcinoma for tumor response to sunitinib
por: Gruenwald, Viktor, et al.
Publicado: (2010)

Clinical value of folate receptor-positive circulating tumor cells in patients with esophageal squamous cell carcinomas: a retrospective study
por: Zhou, Qiang, et al.
Publicado: (2023)

Clinical significance of circulating tumour cells and Ki-67 in renal cell carcinoma
por: Song, Jinbo, et al.
Publicado: (2021)

The combination of preoperative platelet count and neutrophil lymphocyte ratio as a prognostic indicator in localized renal cell carcinoma
por: Tsujino, Takuya, et al.
Publicado: (2017)

Clinical Significance of Circulating Tumor Cells in Gastrointestinal Carcinomas
por: Konczalla, Leonie, et al.
Publicado: (2020)

Prognostic value of circulating tumor cells in esophageal cancer
por: Xu, Hai-Tao, et al.
Publicado: (2017)

A rare case of extremely high counts of circulating tumor cells detected in a patient with an oral squamous cell carcinoma
por: Wu, Xianglei, et al.
Publicado: (2016)

Clinical significance of peripheral circulating tumor cell counts in colorectal polyps and non-metastatic colorectal cancer
por: Yang, Chengguang, et al.
Publicado: (2018)

Cryptotanshinone inhibits proliferation yet induces apoptosis by suppressing STAT3 signals in renal cell carcinoma
por: Chen, Zhiguo, et al.
Publicado: (2017)

Circulating Tumor Cells Count and Morphological Features in Breast, Colorectal and Prostate Cancer
por: Ligthart, Sjoerd T., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_166taqvtl146r56810t0ubohib